With Pfizer EUA For 5-11 And Moderna Delay For Adolescents, US FDA Walks Myocarditis Tightrope

 
• By Nielsen Hobbs

COVID vaccine safety concerns from international analyses will force sponsors and FDA to again confront the challenge of how to make bad news for one shot not turn into bad news for all.

Pfizer orange cap covid vaccine
PFIZER’S VERSION OF ITS COVID VACCINE FOR CHILDREN 5-11 FEATURES A LOWER DOSE AND AN ORANGE-COLORED CAP. • Source: Pfizer

More from Approvals

More from Product Reviews